Table 4. IC50 of the Target Compounds against Human Lung Fibroblast Cell Line WI38.
| compound no. | IC50 in μg/mL WI38 |
|---|---|
| DOX | 8.87 ± 0.6 |
| 3a | 28.20 ± 2.3 |
| 3b | 25.27 ± 2.1 |
| 3c | 64.53 ± 3.8 |
| 3d | 71.21 ± 4.2 |
| 3e | 41.48 ± 2.9 |
| 5a | 65.68 ± 1.1 |
| 5d | 49.86 ± 3.4 |
| 5e | 51.67 ± 3.7 |
| 5f | 43.02 ± 3.1 |
| 5g | 24.86 ± 2.0 |
| 7a | 54.64 ± 3.5 |
| 7b | 41.35 ± 1.7 |
| 7c | 51.91 ± 3.4 |
| 7d | 39.49 ± 1.7 |
| 7e | 27.05 ± 3.3 |
| 7f | 44.50 ± 4.5 |
| 7g | 30.31 ± 1.7 |
| 7h | 25.34 ± 2.2 |
| 7i | 19.49 ± 1.6 |
| 7j | 33.76 ± 2.5 |